| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.2M | -4.4% |
| Cost of Revenue | $15.5M | -4.7% |
| Gross Profit | $8.7M | -3.8% |
| R&D Expense | $70K | -34.6% |
| SG&A Expense | $3.9M | -63.6% |
| Operating Income | -$4.4M | -31.9% |
| Pre-tax Income | -$3.9M | -14.5% |
| Income Tax | $0 | — |
| Net Income | -$3.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.8M | -6.9% |
| Accounts Receivable | $2.6M | -12.6% |
| Inventory | $39K | +2.6% |
| Current Assets | $6.4M | -17.2% |
| Total Assets | $16.1M | -22.4% |
| Current Liabilities | $4.2M | -17.5% |
| Total Liabilities | $5.9M | -28.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $871K | +257.0% |
| Capital Expenditures | $7K | -74.1% |
| Investing Cash Flow | -$575K | +51.9% |
| Financing Cash Flow | -$616K | -197.2% |
| Free Cash Flow | $864K | +298.2% |
| -12.8% |
| EPS (Basic) | -$0.37 | -5.7% |
| EPS (Diluted) | -$0.37 | -5.7% |
| Stockholders' Equity |
| $10.2M |
| -18.5% |